Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.

Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M.

Oxid Med Cell Longev. 2018 Jun 11;2018:9547613. doi: 10.1155/2018/9547613. eCollection 2018. Review.

2.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators.

Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Erratum in: Lancet. 2018 Aug 4;392(10145):386.

PMID:
29861076
3.

Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota.

Morgillo F, Dallio M, Della Corte CM, Gravina AG, Viscardi G, Loguercio C, Ciardiello F, Federico A.

Neoplasia. 2018 Jul;20(7):721-733. doi: 10.1016/j.neo.2018.05.002. Epub 2018 May 30. Review. No abstract available.

4.

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets.

Gravina AG, Dallio M, Masarone M, Rosato V, Aglitti A, Persico M, Loguercio C, Federico A.

Oxid Med Cell Longev. 2018 Apr 12;2018:2568569. doi: 10.1155/2018/2568569. eCollection 2018. Review.

5.

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

Belli V, Sforza V, Cardone C, Martinelli E, Barra G, Matrone N, Napolitano S, Morgillo F, Tuccillo C, Federico A, Dallio M, Loguercio C, Gravina AG, De Palma R, Ciardiello F, Troiani T.

Oncotarget. 2017 Aug 7;8(40):68305-68316. doi: 10.18632/oncotarget.20054. eCollection 2017 Sep 15.

6.

Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis.

Federico A, Dallio M, Caprio GG, Gravina AG, Picascia D, Masarone M, Persico M, Loguercio C.

Nutrients. 2017 Sep 28;9(10). pii: E1074. doi: 10.3390/nu9101074.

7.

Gut microbiota and the liver.

Federico A, Dallio M, Caprio GG, Ormando VM, Loguercio C.

Minerva Gastroenterol Dietol. 2017 Dec;63(4):385-398. doi: 10.23736/S1121-421X.17.02375-3. Review.

PMID:
28927250
8.

Gut microbiota, obesity and metabolic disorders.

Federico A, Dallio M, DI Sarno R, Giorgio V, Miele L.

Minerva Gastroenterol Dietol. 2017 Dec;63(4):337-344. doi: 10.23736/S1121-421X.17.02376-5. Review.

PMID:
28927249
9.

Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.

Dallio M, Masarone M, Caprio GG, Di Sarno R, Tuccillo C, Sasso FC, Persico M, Loguercio C, Federico A.

J Gastrointestin Liver Dis. 2017 Sep;26(3):261-268. doi: 10.15403/jgld.2014.1121.263.dal.

10.

Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis.

Persico M, Rosato V, Aglitti A, Precone D, Corrado M, De Luna A, Morisco F, Camera S, Federico A, Dallio M, Claar E, Caporaso N, Masarone M.

Antivir Ther. 2018;23(2):129-138. doi: 10.3851/IMP3186.

PMID:
28799522
11.

A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells.

Federico A, Conti V, Russomanno G, Dallio M, Masarone M, Stiuso P, Tuccillo C, Caraglia M, Manzo V, Persico M, Filippelli A, Loguercio C.

In Vivo. 2017 Jul-Aug;31(4):609-618.

12.

Human exposure to Bisphenol A and liver health status: Quantification of urinary and circulating levels by LC-MS/MS.

Nicolucci C, Errico S, Federico A, Dallio M, Loguercio C, Diano N.

J Pharm Biomed Anal. 2017 Jun 5;140:105-112. doi: 10.1016/j.jpba.2017.02.058. Epub 2017 Mar 10.

PMID:
28346880
13.

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.

Federico A, Dallio M, Loguercio C.

Molecules. 2017 Jan 24;22(2). pii: E191. doi: 10.3390/molecules22020191. Review.

14.

Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required?

Federico A, Brancaccio G, Dallio M, Iodice P, Fabozzi A, Del Prete S, Ciardiello F, Loguercio C, Gaeta GB.

Dig Liver Dis. 2017 Feb;49(2):197-201. doi: 10.1016/j.dld.2016.11.004. Epub 2016 Nov 16.

PMID:
27899262
15.

Epidemiology and Natural History of Alcoholic Liver Disease.

Masarone M, Rosato V, Dallio M, Abenavoli L, Federico A, Loguercio C, Persico M.

Rev Recent Clin Trials. 2016;11(3):167-74. Review.

PMID:
27515957
16.

Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.

Godos J, Federico A, Dallio M, Scazzina F.

Int J Food Sci Nutr. 2017 Feb;68(1):18-27. doi: 10.1080/09637486.2016.1214239. Epub 2016 Aug 2. Review.

PMID:
27484357
17.

Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment.

Abenavoli L, Masarone M, Federico A, Rosato V, Dallio M, Loguercio C, Persico M.

Rev Recent Clin Trials. 2016;11(3):159-66. Review.

PMID:
27457347
18.

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.

Federico A, Zappavigna S, Dallio M, Misso G, Merlino F, Loguercio C, Novellino E, Grieco P, Caraglia M.

Curr Cancer Drug Targets. 2017;17(2):109-121. doi: 10.2174/1568009616666160621101248. Review.

PMID:
27338741
19.

Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.

Federico A, Dallio M, Tolone S, Gravina AG, Patrone V, Romano M, Tuccillo C, Mozzillo AL, Amoroso V, Misso G, Morelli L, Docimo L, Loguercio C.

In Vivo. 2016 May-Jun;30(3):321-30.

PMID:
27107092
20.

Postoperative Changes in Fecal Bacterial Communities and Fermentation Products in Obese Patients Undergoing Bilio-Intestinal Bypass.

Patrone V, Vajana E, Minuti A, Callegari ML, Federico A, Loguercio C, Dallio M, Tolone S, Docimo L, Morelli L.

Front Microbiol. 2016 Feb 23;7:200. doi: 10.3389/fmicb.2016.00200. eCollection 2016.

Supplemental Content

Loading ...
Support Center